(Q39372756)

11 September 2017

title

Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment (English)

1 reference

José Antonio Pérez-Molina

11 September 2017

0 references

1 reference

object named as

José A Pérez-Molina

series ordinal

1

0 references

author name string

Francesca Norman

series ordinal

2

1 reference

11 September 2017

Rogelio López-Vélez

series ordinal

3

1 reference

11 September 2017

publication date

1 June 2012

1 reference

Current infectious disease reports

11 September 2017

published in

1 reference

11 September 2017

volume

14

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

263-274

1 reference

Chagas disease and the US blood supply

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Congenital transmission of Chagas disease: a clinical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Trypanosoma cruzi and Chagas' Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Chagasic cardiomyopathy in immigrants from Latin America to Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Survey of obstetrician-gynecologists in the United States about Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Chagas cardiomyopathy in the context of the chronic disease transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Evaluation and treatment of chagas disease in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Screening and treatment of chagas disease in organ transplant recipients in the United States: recommendations from the chagas in transplant working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Guidelines on the treatment of chronic coinfection by Trypanosoma cruzi and HIV outside endemic areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Lack of association between blood-based detection of Trypanosoma cruzi DNA and cardiac involvement in a non-endemic area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Usefulness of qualitative polymerase chain reaction for Trypanosoma cruzi DNA in endomyocardial biopsy specimens of chagasic heart transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American Migrants in Geneva, Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Utilidad de un test inmunocromatográfico para el cribado de la enfermedad de Chagas en asistencia primaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

A critical review on Chagas disease chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Trypanocidal drugs: mechanisms, resistance and new targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Update in treatment of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Chronic phase of Chagas disease: why should it be treated? A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Tolerance of benznidazole in treatment of Chagas' disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Adverse events after the use of benznidazole in infants and children with Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Tolerance and safety of nifurtimox in patients with chronic chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Treatment of chronic Chagas' disease with an association of nifurtimox and corticoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Advances in Chagas disease drug development: 2009-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Reactivation of Chagas' disease in a patient with non-Hodgkin's lymphoma: gastric, oesophageal and laryngeal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Development and validation of a risk score for predicting death in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Clinical predictors of chronic chagasic myocarditis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Predictors of mortality in chronic Chagas disease: a systematic review of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas Disease cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Chagas disease and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

An Estimate of the Burden of Chagas Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

21 January 2018

12 December 2020

Associação entre dissinergia miocárdica e arritmia ventricular na forma indeterminada da doença de Chagas

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0259-3

Administration of benznidazole, a chemotherapeutic agent against Chagas disease, to pregnant rats. Covalent binding of reactive metabolites to fetal and maternal proteins.

21 January 2018

1 reference

12 December 2020

Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection

1 reference

12 December 2020

[Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation]

1 reference

12 December 2020

The effect of nifurtimox in acute Chagas' infection

1 reference

12 December 2020

The hidden Chagas disease burden in Europe

1 reference

12 December 2020

Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996

1 reference

12 December 2020

Etiological drug treatment of human infection by Trypanosoma cruzi.

1 reference

12 December 2020

[Treatment of the undetermined form of Chagas disease with nifortimox and benzonidazole]

1 reference

12 December 2020

Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)

1 reference

12 December 2020

[Brazilian Consensus on Chagas disease]

1 reference

12 December 2020

Congenital Chagas disease in Córdoba, Argentina: epidemiological, clinical, diagnostic, and therapeutic aspects. Experience of 30 years of follow up

1 reference

12 December 2020

Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial

1 reference

12 December 2020

Treatment of Chagas disease with benznidazole and thioctic acid

1 reference

12 December 2020

Single-dose pharmacokinetics of the trypanosomicide benznidazole in man

1 reference

12 December 2020

The treatment of Chagas disease (South American trypanosomiasis)

1 reference

12 December 2020

Long term evaluation of etiological treatment of chagas disease with benznidazole.

1 reference

12 December 2020

Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome

1 reference

12 December 2020

The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology

1 reference

12 December 2020

Congenital Chagas disease: experience in the Hospital de Niños, Ricardo Gutiérrez, Buenos Aires, Argentina

1 reference

12 December 2020

Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010.

1 reference

12 December 2020

Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications

1 reference

12 December 2020

Mutagenicity of nifurtimox and benznidazole in the Salmonella/microsome assay.

1 reference

12 December 2020

Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole.

1 reference

12 December 2020

Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy

1 reference

12 December 2020

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

12 December 2020

Reactivation of Chagas' myocarditis during therapy of Hodgkin's disease

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease

1 reference

12 December 2020

Electrocardiographic classification and abbreviated lead system for population-based studies of Chagas' disease

1 reference

12 December 2020

Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution

1 reference

12 December 2020

Chagas' heart disease

1 reference

12 December 2020

Chagas disease in European countries: the challenge of a surveillance system.

1 reference

12 December 2020

Chagas disease in Latin American migrants: a Spanish challenge.

1 reference

12 December 2020

10.1007/S11908-012-0259-3

Identifiers

DOI

1 reference

11 September 2017

1 reference